Precision Medicine, Real-World Data / Evidence, immune system, multiomics and artificial intelligence (AI)
In addition to my contribution on the IHLAD channel, I would like to highlight a nature paper from 2021: "Achieving a three-dimensional #longevity dividend" „Longer, healthier lives should be good for individual welfare as well as positive for the economy. However, concern exists because an #aging society is producing substantial shifts in the population structure and longevity gains are increasingly occurring in years of below-average #health and #economic activity. This requires investment in healthy and productive aging to achieve a longevity dividend, which in turn involves exploiting the malleability of age and the additional time that longer lives bring… Exploiting the malleability of age is a broad agenda extending well beyond the health sector to include behavior and socioeconomic factors. Healthy aging provides a platform for productive aging, as longer lives will require longer working careers. Increased employment among older workers has already been an important source of growth, but a number of barriers to productive aging need to be tackled. Continued employment for those over 50 years of age, more flexible career paths and a substantial growth in adult education are key priorities.“ Scott, A.J. Achieving a three-dimensional longevity dividend. Nat Aging 1, 500–505 (2021). https://lnkd.in/eCDN5tcu
Will our grandchildren still be that kind of human being in which we define humanity today? Innovations in #biotech, #health technology and #AI challenge our understanding of what it means to be human. By our COO, Rudi Schmidt Take, for example, enhancements of human #cognitive or physical capabilities. Two weeks ago, Swiss researchers published that they have succeeded in developing a next-generation miniaturized brain-machine interface capable of direct brain-to-text communication on tiny silicon chips. This breakthrough in miniaturization brings help to patients with amyotrophic lateral sclerosis (ALS), locked-in syndrome or spinal cord injury in the realm of realistic possibilities. On the other hand, the need to redefine our identity, our self and also our economy is now visible on the horizon. The evolving #brain-computer interfaces and neuroprosthetics will foster economic development by creating new industries and enhancing productivity across an extended healthy lifespan. Healthy #longevity could be a boon for productivity. The speed at which we race along this innovation track prompts questions about technological determinism. Our society will be shaped in more fundamental ways than we knew it from the past century, influencing our social structures, relationships, cultural norms ad last but not least our markets. Technologies that are already highly profitable business models in biomedical markets can also be commercialized in other industries. Since the medical sector usually has higher demands on reliability and safety than the other industries, a reverse flow of innovation from these industries is confronted with relatively high barriers to market entry. For economies that want to benefit structurally from these innovations (and that can afford the high investments), there are several fields of technology. To name only few examples: Medical AI, neuroenhancements and a the economics of longevity will not only impact health insurances (risk assessments) but also the finance sector. Financial decision models will change, for example, because of the work life expectancy of borrowers. Virtual, extended and #AugmentedReality (XR, AR): will not only be used in telemedicine for diagnostics and treatment. This combination will also impact retail and Real Estate technologies for new building features of shopping malls, clinics, smart homes or schools and universities (education). Biotech innovations have significantly advanced various fields of science and research, driving economic development. This progress is evident in the rise of patent filings and the establishment of numerous new companies, often within specialized clusters. For instance, the development of MedTech typically involves a collaborative network of research centers, hospitals, companies, and manufacturers, forming technological ecosystems. Moreover, the full potential of Social Return on Investment (SROI) in health and biotech remains to be fully explored.
Hatem Abueida
3mo
Thanks for sharing
Pegah Shakibnia
3mo
Insightful points and remarkable share as always. Thank you Rudi Schmidt.👌🏻🙏🏻
Sabine Mueller
3mo
Rudi Schmidt thanks for sharing!
Excellent, Congratulations Rudi Schmidt!
Creating and executing Digital and Technology strategies in alignment with corporate vision. Focus on Innovation, Design thinking to deliver intuitive solutions (CX & UX), Analytics & automated operational excellence
3moVery true Rudi, In the coming decades, we can expect BCI supported by AI and biotech to not only enhance the health and well being but also can have a drastic impact on economic throughput by enhancing human capabilities (and “augmented capabilities”)